रैंकिंग पर वापस जाएं

Exponent, Inc. (EXPO)

Fair Value
IndustrialsEngineering & ConstructionUnited States

Fundamental

63

मूल्य

$69.33

मार्केट कैप

$3.11B

भाग 1 · कंपनी का मूल्य कितना है

अवलोकन

Exponent is a science and engineering consulting firm that is hired to figure out why something failed, or to check whether a product, plant or chemical is safe before it is released. Its staff of more than 90 technical disciplines works across 17 practices, from biomechanics and civil engineering to vehicle engineering, data sciences, chemical regulation and health sciences. As of January 2, 2026 it employed 1,212 people, including 949 engineering and scientific staff, of whom 922 hold advanced degrees and 731 a doctorate. The work splits between reactive assignments — accident and product-failure investigations, often tied to litigation, insurance claims or regulatory proceedings — and proactive assignments, where clients bring Exponent in during design, testing or regulatory approval. There is no factory and no product: the asset being sold is the credibility of the people who sign the report and, when needed, testify.

यह पैसा कैसे कमाती है

Exponent sells the hours of its consultants. Engagements are performed mainly on a time-and-materials basis, billing hourly rates for each staff member according to skills and experience, with standard professional rates ranging from $225 to $1,375 per hour; some work is done on a fixed-price basis. Engagement agreements typically provide for monthly billing with payment due within 30 days. The company reports two revenue lines: total revenues and 'revenues before reimbursements', which strips out pass-through costs rebilled to clients; in fiscal 2025 total revenues were $582.0 million and revenues before reimbursements $536.8 million. Growth therefore comes from three levers only: headcount, utilisation of that headcount, and billing rates.

सेगमेंट के अनुसार राजस्व

Engineering and Other Scientific84%

The larger segment, covering the engineering practices — biomechanics, civil and structural engineering, vehicle engineering, materials, electrical and data sciences among them. It serves manufacturers, utilities, insurers and law firms that need a technical explanation of a failure, an accident or a design question. Share is of revenues before reimbursements for fiscal 2025.

Environmental and Health16%

Consulting on environmental hazards, chemical regulation, ecological and earth sciences, epidemiology and health risk — assessing the effect of substances and sites on human health and the environment. Clients are chemical and life-science companies, industrial operators and their counsel. Share is of revenues before reimbursements for fiscal 2025.

प्रतिस्पर्धी बढ़त (Moat)

पेटेंट और लाइसेंस · संकीर्ण

What Exponent sells cannot easily be copied or bought: a bench of 949 technical staff, 731 of them with doctorates, whose conclusions have to withstand cross-examination in court and scrutiny by regulators. The company itself states that its business is dependent on its professional reputation and that damage to that reputation would materially affect results. Independence adds a second layer: because Exponent takes no positions and does not design what it later judges, clients in adversarial proceedings can use its work — and the company notes it must sometimes decline engagements to avoid conflicts of interest. This is a reputation-and-people advantage, not a structural one: the staff can be hired away, there are no long-term contracts, and nothing stops a rival firm of experts from competing for the same case.

मांग को क्या चलाता है

मध्यम रूप से चक्रीय

Demand has two halves that do not move together. The reactive half — accident investigations, product failures, disputes and insurance claims — is triggered by events rather than by the economy, and can hold up or even rise when conditions worsen, which is why the company describes performance as uneven rather than simply cyclical. The proactive half, where Exponent is hired during design, testing and regulatory approval, tracks clients' R&D and capital budgets and is cut when those budgets are cut. Fiscal 2025 shows the two segments diverging: engineering and other scientific revenues before reimbursements grew 4% while environmental and health was approximately flat. Exposure is spread across industries: in 2025 approximately 21%, 20%, 16% and 11% of revenues came from clients in consumer products, energy and utilities, transportation and chemicals respectively. There is no backlog to smooth the year — the work is billed by the hour as it happens.

प्रमुख जोखिम

  • The business is reactive and hard to predict — Exponent states that the unpredictable and reactive nature of its business can create uneven performance in any given quarter or year: much of the work follows accidents, failures and disputes that cannot be scheduled, so revenue does not arrive smoothly.
  • Losing a large client — The company lists the loss of a large client as a risk that could have a material adverse effect on its business, financial condition or results of operations. It also flags that clients may terminate, cancel, modify or curtail contracts, and that clients may be unable to pay for services rendered.
  • Everything depends on attracting and keeping the experts — Exponent identifies failure to attract and retain key employees as a risk factor. With no product and no plant, the consultants are the asset, and a business that grows by adding billable hours cannot grow if it cannot recruit.
  • Artificial intelligence, on both sides — The filing carries two distinct AI risk factors: that AI technologies may reduce demand for the company's services, and that Exponent's own adoption and use of AI technologies carries risks.
  • Regulation and tort reform move demand — The company states that its business can be adversely impacted by regulatory uncertainty and that tort reform can reduce demand for its services — a change in liability law directly shrinks the pool of disputes that generate work.
  • Conflicts of interest force work to be turned down — Exponent notes that potential conflicts of interest may preclude it from accepting engagements — the independence that makes the work credible also means revenue is deliberately refused.
  • Professional liability and litigation — The company discloses that its engagements may result in professional or other liability and that it is subject to unpredictable risks of litigation, as well as risks from employee or contractor misconduct.
  • Information systems, security breaches and data protection — Exponent states that it is subject to security breaches, that laws on data protection continue to evolve rapidly, and that its business depends on its ability to use and access its information systems — it holds confidential client material central to disputes.
  • Government contracts and international operations — The filing flags inherent risks related to government contracts, special risks created by international operations, and the risk of failing to comply with domestic and international export laws.

ग्राहक Concentration

The filing does not disclose the share of revenues taken by the largest client or by the top clients as a group, and there is no statement that no single client exceeded a given threshold. What it does give is industry concentration: in 2025 approximately 21% of revenues came from consumer products clients, 20% from energy and utilities, 16% from transportation and 11% from chemicals. The company does list the loss of a large client among its risk factors, which indicates individual clients matter, but it puts no number on it. Treat the concentration as undisclosed rather than as low.

खरीदने के पक्ष में तर्क

Buyers argue that Exponent sells something a competitor cannot simply undercut: 949 technical staff, 731 of them holding doctorates, whose analysis has to survive a courtroom and a regulator. That reputation supports standard rates of up to $1,375 an hour and, buyers argue, room to raise them. They point to a business with no factory, no inventory and no long-term contracts to honour, so cash converts quickly and the balance sheet carries little operational weight. They note the work arrives from both directions — failures and disputes when things go wrong, design and regulatory support when clients invest — across consumer products, energy and utilities, transportation and chemicals, so no single end market dictates the year. Fiscal 2025 revenues grew 4.2% to $582.0 million, with the engineering segment up 4% before reimbursements. Buyers also argue that new technologies, including AI systems themselves, create new categories of failure that someone independent will have to examine.

बेचने के पक्ष में तर्क

Sellers fear a business that can only grow by hiring: revenue is headcount times utilisation times rate, and the company itself lists failure to attract and retain key employees among its risks. They point to fiscal 2025 growth of 4.2% in total revenues and 3.5% before reimbursements, with the environmental and health segment approximately flat, as evidence the machine is running near its limit. They take seriously Exponent's own statement that AI technologies may reduce demand for its services, since a meaningful part of the work is analysis and document-heavy investigation. They note the company's warning that tort reform can reduce demand and that regulatory uncertainty can hurt it — the pipeline depends on rules the company does not control. They also fear the timing risk the filing concedes outright: the reactive, unpredictable nature of the work makes quarters uneven, there is no backlog, and conflicts of interest force paying engagements to be refused. Finally, the filing discloses no client-concentration figure, so sellers argue the exposure to any one large client cannot be checked from the outside.

Generated on 18 सितंबर 2026 with claude-haiku-4-5 — shared with all users

Direct competitors

Who this company fights with for the same customers

Generated on 18 सितंबर 2026 with claude-haiku-4-5 — shared with all users

J.S. Held LLCNot tracked

J.S. Held sells the same forensic engineering and expert-witness investigations — structural, mechanical, materials and biomechanical failure analysis — to the insurers, law firms and manufacturers that make up Exponent's litigation-driven client base.

Rimkus Consulting Group, Inc.Not tracked

Rimkus competes for the same accident-investigation, failure-analysis and construction-dispute assignments from insurers and defence counsel, in the same North American and international markets.

Envista ForensicsNot tracked

Envista bids for the same insurance-claim and product-liability investigations, offering multidisciplinary forensic engineers and testifying experts on the equipment, fire and structural failures Exponent also investigates.

Charles River Associates (CRA International, Inc.)CRAI

CRA competes for the litigation and regulatory consulting budget of the same corporate clients and law firms, selling expert testimony and analysis on product, energy and life-sciences disputes.

FTI Consulting, Inc.FCN

FTI's construction, forensic and expert-services practices pursue the same dispute-related engagements from insurers, corporations and their counsel that drive a large share of Exponent's billings.

बैलेंस शीट और तरलता

राजस्व

$632M

पिछले 12 महीने (3/7/2026 तक)

शुद्ध आय

$112M

पिछले 12 महीने (3/7/2026 तक)

Free Cash Flow

$122M

कुल इक्विटी

$390M

कुल देनदारियाँ

$387M

Current Ratio

1.98

Interest Coverage

-

Debt/EBITDA

0.62

Earnings Per Share

राजस्व और शुद्ध आय

Free Cash Flow

आय विवरण

ऐतिहासिक विवरण

समय के साथ मार्जिन

समय के साथ ऋण

ऋण कितना भारी है

वृद्धि तालिका

वृद्धि — राजस्व

Fair Value अनुमान

सामान्य मामलाउचित मूल्यांकित

Fair Value

$62.95

वर्तमान मूल्य

$69.33

Margin of Safety

-10.1%

Fair Value सीमा

$44.49 - $81.40

इस्तेमाल किए गए valuation methods के बीच का फैलाव, कोई सांख्यिकीय रूप से calibrated confidence interval नहीं।

अनुमान विधियाँ

विश्लेषकों का लक्ष्य मूल्य:$84.00
डिस्काउंटेड कैश फ्लो (DCF):$61.11
आय गुणक (P/E):$58.20
Graham वृद्धि फॉर्मूला:$39.57
अर्निंग पावर वैल्यू (EPV):$21.84
उचित P/B:$42.57
लाभांश डिस्काउंट (Gordon):$28.83
P/FFO, परिचालन से प्राप्त निधि:$39.07
मध्य-चक्र आय:$59.85
राजस्व गुणक:$34.20
विश्लेषक सहमति:दृढ़ खरीदें (8B / 2H / 0S)
अंतिम Earnings सरप्राइज़:+6.95%

मूल्यांकन मेट्रिक्स

P/E Ratio

29.47

ROE

27.2%

P/B Ratio

10.78

P/FCF

28.65

Gross Margin

-

ROIC

20.4%

लाभप्रदता Radar

मूल्य सृजन (प्रतिस्पर्धी बढ़त)

ROIC

20.4%

WACC

8.2%

ROIC − WACC

+12.2 pp

ROIC पूंजी की लागत से अधिक है — कंपनी शेयरधारकों के लिए मूल्य सृजित कर रही है।

Fundamental विश्लेषण मानदंड

पास (19)

  • EPS shows upward trend
  • Price CAGR 8.05%
  • ROIC 20.4%
  • P/FCF 28.65
  • Debt/Equity ratio
  • Operating Margin 20.2%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • ROE 27.9%
  • Revenue Growth 5Y 7.8%
  • Analyst Consensus 80% Buy
  • Earnings Surprise avg 4.3%
  • Earnings Quality (OCF/NI) 1.06
  • Share Dilution -0.9%
  • Piotroski F-Score 5/9

फेल (6)

  • EPS CAGR 2.16%
  • P/B Ratio 10.78
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • PEG Ratio 4.78
  • Net Margin Trend 17.7% vs 18.3%

अनुपलब्ध (3)

  • Gross Margin NaN%
  • Dividend Payout NaN%
  • Interest Coverage

Piotroski F-Score

5/9

मिश्रित संकेत: कुछ क्षेत्रों पर ध्यान देना आवश्यक

score
criteria

Earnings गुणवत्ता

1.06

उच्च गुणवत्ता: earnings नकदी द्वारा समर्थित

शेयर Dilution

-0.9%

शेयर वापस खरीद रही है। शेयरधारक अनुकूल

संस्थागत होल्डिंग

प्रशासन

कार्यकारी टीम

नामपदआयु
Dr. Catherine Ford Corrigan P.E., Ph.D.CEO & Director56
Mr. Richard L. Schlenker Jr.Executive VP, Corporate Secretary & Director59
Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D.Group Vice President56
Dr. Joseph Rakow Ph.D.Group Vice President48
Dr. Joseph Sala Ph.D.Group Vice President48
Dr. John D. Pye P.E., Ph.D.President54
Dr. Bernard Ross P.E., Ph.D.Co-Founder & Principal Engineer-
Mr. Eric R. AndersonChief Financial Officer50
Ms. Gina FlynnVP of Legal & General Counsel-
Mr. Brian KundertChief Human Resources Officer50

Audit जोखिम

9

बोर्ड जोखिम

2

मुआवजा जोखिम

4

शेयरधारक अधिकार जोखिम

2

भाग 2 · कीमत और खरीदने का समय

यह हिस्सा यह नहीं बताता कि कंपनी अच्छी है या नहीं: यह तय करने में मदद करता है कि उसे कब खरीदें, जब फंडामेंटल आपको आश्वस्त कर चुके हों। इसमें: तकनीकी विश्लेषण, संभावना, ऐतिहासिक गिरावट, गामा एक्सपोज़र।

दस्तावेज़

  • वार्षिक रिपोर्ट (10-K)

    कंपनी के कारोबार, वित्तीय नतीजों और जोखिमों का वार्षिक सिंहावलोकन।

    दाखिल तिथि: 2026-02-27

    दस्तावेज़ देखें
  • तिमाही रिपोर्ट (10-Q)

    पिछले तीन महीनों के वित्तीय प्रदर्शन का अपडेट।

    दाखिल तिथि: 2026-08-07

    दस्तावेज़ देखें
  • विशेष रिपोर्ट (8-K)

    किसी बड़ी घटना, जैसे नेतृत्व में बदलाव या बड़ी घोषणा, की सूचना।

    दाखिल तिथि: 2026-07-30

    दस्तावेज़ देखें

via SEC EDGAR

आय का इतिहास

via SEC EDGAR

Latest News

Recent headlines for EXPO, sourced from Markets Gazette.

No recent news for EXPO.
Disclaimer

यह प्लेटफ़ॉर्म केवल शैक्षिक उद्देश्यों के लिए है। यह कोई वित्तीय, निवेश, या ट्रेडिंग सलाह नहीं देता। सभी स्कोर, मूल्यांकन, और संकेत सार्वजनिक रूप से उपलब्ध डेटा के स्वचालित विश्लेषण पर आधारित हैं जो अधूरे या गलत हो सकते हैं। निवेश निर्णय लेने से पहले हमेशा अपना शोध करें और एक योग्य वित्तीय सलाहकार से परामर्श लें।

निर्मित द्वारा CODEPRESS s.r.l.